The transcriptional repressor HIC1 regulates intestinal immune homeostasis
暂无分享,去创建一个
V Korinek | T. Underhill | S. Scheer | C. Zaph | K. Burrows | K Burrows | F Antignano | M Bramhall | A Chenery | S Scheer | T M Underhill | C Zaph | M. Bramhall | F. Antignano | A. Chenery | V. Kořínek
[1] J. Lukas,et al. HIC1 attenuates Wnt signaling by recruitment of TCF‐4 and β‐catenin to the nuclear bodies , 2006, The EMBO journal.
[2] S. Rutz,et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells , 2014, Nature.
[3] P. Chambon,et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. , 2008, Immunity.
[4] Charlotte L. Scott,et al. Intestinal CD103+ dendritic cells: master regulators of tolerance? , 2011, Trends in immunology.
[5] D. Leprince,et al. Generation of two modified mouse alleles of the Hic1 tumor suppressor gene , 2011, Genesis.
[6] W. Leonard,et al. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells , 2015, Proceedings of the National Academy of Sciences.
[7] William W. Agace,et al. Functional specialization of gut CD103 dendritic cells in the regulation of tissue-selective T cell homing , 2005 .
[8] Subhashis Banerjee,et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. , 2012, The New England journal of medicine.
[9] J. Bluestone,et al. Control of TH17 cells occurs in the Small Intestine , 2011, Nature.
[10] P. D. Smith,et al. Intestinal macrophages and response to microbial encroachment , 2011, Mucosal Immunology.
[11] C. Bain,et al. Macrophages in intestinal homeostasis and inflammation , 2014, Immunological reviews.
[12] R. Nurieva,et al. Bcl6 Mediates the Development of T Follicular Helper Cells , 2009, Science.
[13] A. Shen,et al. Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription , 2011, Nucleic acids research.
[14] S. Fagarasan. Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut. , 2006, Current topics in microbiology and immunology.
[15] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[16] D. Leprince,et al. Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics , 2013, Expert opinion on therapeutic targets.
[17] R. Proia,et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.
[18] Gisen Kim,et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. , 2009, Immunity.
[19] F. Annunziato,et al. The 3 major types of innate and adaptive cell-mediated effector immunity. , 2015, The Journal of allergy and clinical immunology.
[20] B. Chassaing,et al. Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.
[21] Xiao Han,et al. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer. , 2016, Cancer letters.
[22] J. Daniel,et al. POZ for effect--POZ-ZF transcription factors in cancer and development. , 2006, Trends in cell biology.
[23] J. Herman,et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors , 2003, Nature Genetics.
[24] Russell G. Jones,et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.
[25] D. Leprince,et al. Hypermethylated in Cancer 1 (HIC1) Recruits Polycomb Repressive Complex 2 (PRC2) to a Subset of Its Target Genes through Interaction with Human Polycomb-like (hPCL) Proteins* , 2012, The Journal of Biological Chemistry.
[26] J. O’Shea,et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. , 2010, Immunity.
[27] R. Noelle,et al. Seeing through the dark: New insights into the immune regulatory functions of vitamin A , 2015, European journal of immunology.
[28] V. Laudet,et al. Genome-wide in Silico Identification of New Conserved and Functional Retinoic Acid Receptor Response Elements (Direct Repeats Separated by 5 bp)* , 2011, The Journal of Biological Chemistry.
[29] T. Mcclanahan,et al. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. , 2015, Immunity.
[30] Hilde Cheroutre,et al. Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.
[31] Graham M Lord,et al. Retinoic Acid Is Essential for Th1 Cell Lineage Stability and Prevents Transition to a Th17 Cell Program , 2015, Immunity.
[32] P. Puigserver,et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.
[33] W. Paul,et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells , 2008, Nature Immunology.
[34] C. Elson,et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.
[35] Marc Vandemeulebroecke,et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.
[36] E. Podack,et al. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine , 2002, Gut.
[37] J. Ortonne,et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.
[38] S. Targan,et al. Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease , 2012 .
[39] G. V. D. Windt,et al. Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.
[40] S. Kang,et al. Complementary roles of retinoic acid and TGF-β1 in coordinated expression of mucosal integrins by T cells , 2010, Mucosal Immunology.
[41] T. Mcclanahan,et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.
[42] O. Lantz,et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. , 2008, Immunity.
[43] M. Genovese,et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. , 2010, Arthritis and rheumatism.
[44] F. Powrie,et al. Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.
[45] C. Elson,et al. Adaptive immunity in the host–microbiota dialog , 2011, Mucosal Immunology.
[46] Erin Stevens,et al. Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation. , 2015, Immunity.
[47] Hiroshi Kawamoto,et al. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate , 2008, Nature Immunology.
[48] D. Leprince,et al. Differential Regulation of HIC1 Target Genes by CtBP and NuRD, via an Acetylation/SUMOylation Switch, in Quiescent versus Proliferating Cells , 2010, Molecular and Cellular Biology.
[49] Si-young Song,et al. Retinoic acid imprints gut-homing specificity on T cells. , 2004, Immunity.
[50] L. Staudt,et al. BCL-6 expression during B-cell activation. , 1996, Blood.
[51] S. Jameson,et al. Transcriptional downregulation of S1pr1 is required for establishment of resident memory CD8+ T cells , 2013, Nature Immunology.
[52] R. Caspi,et al. Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses. , 2011 .
[53] S. Baylin,et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.
[54] M. Lazar,et al. Activation of retinoic acid receptor‐α favours regulatory T cell induction at the expense of IL‐17‐secreting T helper cell differentiation , 2007, European journal of immunology.
[55] Sung-Uk Lee,et al. POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function , 2012, Immunological reviews.
[56] D. Beier,et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. , 1999, Journal of immunology.
[57] D. Leprince,et al. Molecular dissection of the interaction between HIC1 and SIRT1. , 2012, Biochemical and biophysical research communications.
[58] D. Leprince,et al. HIC1 interacts with and modulates the activity of STAT3 , 2013, Cell cycle.
[59] R. Coffman,et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.
[60] Dan R. Littman,et al. Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.
[61] S. Baylin,et al. Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses , 2005, Cell.
[62] Y. Belkaid,et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. , 2011, Immunity.
[63] Hilde Cheroutre,et al. The light and dark sides of intestinal intraepithelial lymphocytes , 2011, Nature Reviews Immunology.